{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:30:31Z","timestamp":1791901831225,"version":"4.3.4"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Vitiligo is a chronic disorder causing skin depigmentation with global prevalence varying from 0\u00b72% to 1\u00b78%. U.K. guidelines recommend assessment of psychological state during clinical evaluation of vitiligo. However, the prevalence of psychological comorbidity in people with vitiligo has not been described.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To establish the prevalence of psychological symptoms or disorders in people with vitiligo and describe the outcome measures used.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a comprehensive search of MEDLINE, Embase, CINAHL and PsycINFO to identify observational studies assessing the prevalence of psychological symptoms or disorders (December 2016). DerSimonian and Lard random-effects models were used to estimate the overall pooled prevalence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 29 studies with 2530 people with vitiligo. Most studies included a measure of either depression (n =25) or anxiety (n =13). The commonest tools were the Hospital Anxiety and Depression Scale and the Centre for Epidemiology Studies Depression Scale. Ten studies provided information on 13 other psychological outcomes. Pooled prevalence using depression-specific and anxiety-specific questionnaires was 0\u00b729 [95% confidence interval (CI) 0\u00b721\u20130\u00b738] and 0\u00b733 (95% CI 0\u00b718\u20130\u00b749), respectively. Prevalence was lower for clinically diagnosed depression (0\u00b721, 95% CI 0\u00b715\u20130\u00b728) and anxiety (0\u00b715, 95% CI 0\u00b706\u20130\u00b724). When nonspecific tools were used the prevalence remained similar for depression (0\u00b727, 95% CI 0\u00b708\u20130\u00b746) but increased for anxiety (0\u00b746, 95% CI 0\u00b739\u20130\u00b752). High heterogeneity was observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A range of psychological outcomes are common in people with vitiligo. The prevalence of anxiety was influenced by type of screening tool, suggesting the need for validation of psychological outcome screening tools in the field of dermatology.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/bjd.16049","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T11:16:43Z","timestamp":1507547803000},"page":"863-878","source":"Crossref","is-referenced-by-count":105,"title":["The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"178","author":[{"given":"O.","family":"Osinubi","sequence":"first","affiliation":[{"name":"Division of Epidemiology & Public Health University of Nottingham Nottingham U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Grainge","sequence":"additional","affiliation":[{"name":"Division of Epidemiology & Public Health University of Nottingham Nottingham U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hong","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust Nottingham U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Watford General Hospital Watford U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Batchelor","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology Division of Rheumatology & Orthopaedics University of Nottingham Nottingham U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0992-7182","authenticated-orcid":false,"given":"D.","family":"Grindlay","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology Division of Rheumatology & Orthopaedics University of Nottingham Nottingham U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Psychology University of Sheffield U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-5100","authenticated-orcid":false,"given":"S.","family":"Ratib","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology Division of Rheumatology & Orthopaedics University of Nottingham Nottingham U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,1]]},"reference":[{"key":"2023011316192313300_bjd16049-bib-0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"2023011316192313300_bjd16049-bib-0002","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guidelines for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0003","first-page":"e163806","article-title":"The prevalence of vitiligo: a meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLOS ONE"},{"key":"2023011316192313300_bjd16049-bib-0004","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2023011316192313300_bjd16049-bib-0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: danger from within","volume":"25","author":"Richmond","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"2023011316192313300_bjd16049-bib-0006","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.12166","article-title":"Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms","volume":"168","author":"Gey","year":"2013","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0007","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"2","author":"Whitton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2023011316192313300_bjd16049-bib-0008","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","article-title":"Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)","volume":"69","author":"Lilly","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0009","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2230.2002.01025.x","article-title":"Comparison of assessments of severity and quality of life in cutaneous disease","volume":"27","author":"Jayaprakasam","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0010","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2133.2000.03830.x","article-title":"Impaired quality of life of adults with skin disease in primary care","volume":"143","author":"Harlow","year":"2000","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0011","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-4362.2000.00793.x","article-title":"Quality of life in dermatology","volume":"39","author":"Halioua","year":"2000","journal-title":"Int J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0012","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","article-title":"Psychologic effects of vitiligo: a critical incident analysis","volume":"35","author":"Kent","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0013","doi-asserted-by":"crossref","DOI":"10.1002\/9780470760116","volume-title":"Vitiligo","author":"Hann","year":"2000"},{"key":"2023011316192313300_bjd16049-bib-0014","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bjd.15199","article-title":"Vitiligo and depression: a systematic review and meta-analysis of observational studies","volume":"177","author":"Lai","year":"2017","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0015","first-page":"530","article-title":"Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership","volume":"164","author":"Eleftheriadou","year":"2011","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0016","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1111\/bjd.15933","article-title":"Quality of life in people with vitiligo: a systematic review and meta-analysis","volume":"177","author":"Morrison","year":"2017","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0017","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Med"},{"key":"2023011316192313300_bjd16049-bib-0018","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"key":"2023011316192313300_bjd16049-bib-0019","volume-title":"The Newcastle Ottawa Scale for assessing quality of nonrandomised studies in meta-analysis","author":"Ottawa Hospital Research Institute"},{"key":"2023011316192313300_bjd16049-bib-0020","volume-title":"Quality assessment of case-control studies","author":"National Heart, Lung and Blood Institute"},{"key":"2023011316192313300_bjd16049-bib-0021","volume-title":"Quality assessment tool for observational cohort and cross-sectional studies","author":"National Heart, Lung and Blood Institute"},{"key":"2023011316192313300_bjd16049-bib-0022","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2023011316192313300_bjd16049-bib-0023","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2023011316192313300_bjd16049-bib-0024","first-page":"493","article-title":"Response to cosmetic disfigurement: patients with vitiligo","volume":"39","author":"Porter","year":"1987","journal-title":"Cutis"},{"key":"2023011316192313300_bjd16049-bib-0025","first-page":"271","article-title":"Personality profiles in patients with alopecia areata","volume":"42","author":"Delfino","year":"1988","journal-title":"Annal Ital Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0026","first-page":"463","article-title":"Vitiligo: psychological aspects","volume":"29","author":"Vilella","year":"1998","journal-title":"Rev Hosp Psiquiatr La Habana"},{"key":"2023011316192313300_bjd16049-bib-0027","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1365-2133.2000.03831.x","article-title":"Psychiatric morbidity in dermatological outpatients: an issue to be recognized","volume":"143","author":"Picardi","year":"2000","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0028","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1346-8138.2001.tb00004.x","article-title":"Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India","volume":"28","author":"Mattoo","year":"2001","journal-title":"J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0029","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2001.tb00003.x","article-title":"Psychiatric morbidity in psoriasis and vitiligo: a comparative study","volume":"28","author":"Sharma","year":"2001","journal-title":"J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1468-3083.2002.00590.x","article-title":"Psychiatric morbidity in vitiligo: prevalence and correlates in India","volume":"16","author":"Mattoo","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023011316192313300_bjd16049-bib-0031","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.psy.0000132869.96872.b2","article-title":"Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions","volume":"66","author":"Sampogna","year":"2004","journal-title":"Psychosom Med"},{"key":"2023011316192313300_bjd16049-bib-0032","first-page":"632","article-title":"Psychiatric morbidity and quality of life in vitiligo: a case controlled study","volume":"84","author":"Mechri","year":"2006","journal-title":"Tunis Med"},{"key":"2023011316192313300_bjd16049-bib-0033","first-page":"19","article-title":"Frequency and pattern of psychiatric disorders in patients with vitiligo","volume":"19","author":"Ahmed","year":"2007","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"2023011316192313300_bjd16049-bib-0034","first-page":"129","article-title":"Clinical characteristics in 113 Turkish vitiligo patients","volume":"17","author":"Ar\u00fdcan","year":"2008","journal-title":"Acta Dermatoven Alp Pannonica Adrita"},{"key":"2023011316192313300_bjd16049-bib-0035","first-page":"1","article-title":"Comparative study of psychiatric morbidity and QoL in psoriasis, vitiligo and alopecia","volume":"4","author":"Saleh","year":"2008","journal-title":"Egypt Dermatol Online J"},{"key":"2023011316192313300_bjd16049-bib-0036","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","article-title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","volume":"159","author":"Sampogna","year":"2008","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/S0365-05962009000100006","article-title":"[Vitiligo and Emotions]","volume":"84","author":"Nogueira","year":"2009","journal-title":"An Bras Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0038","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4314\/ajpsy.v12i4.49045","article-title":"The psychological impact of vitiligo in adult Sudanese patients","volume":"12","author":"Osman","year":"2009","journal-title":"Afr J Psych"},{"key":"2023011316192313300_bjd16049-bib-0039","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1365-4632.2010.04514.x","article-title":"Beliefs and perceptions of Arab vitiligo patients regarding their condition","volume":"49","author":"AlGhamdi","year":"2010","journal-title":"Int J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0040","first-page":"811","article-title":"Depression in adult dermatology outpatients","volume":"20","author":"Bashir","year":"2010","journal-title":"J Coll Physicians Surg Pak"},{"key":"2023011316192313300_bjd16049-bib-0041","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1468-3083.2009.03452.x","article-title":"Quality of life and psychological adaptation of Korean adolescents with vitiligo","volume":"24","author":"Choi","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023011316192313300_bjd16049-bib-0042","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5350\/DAJPN2011240406","article-title":"Psychiatric morbidity in patients with vitiligo","volume":"24","author":"Balaban","year":"2011","journal-title":"Dusunen Adam"},{"key":"2023011316192313300_bjd16049-bib-0043","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1365-2702.2011.03777.x","article-title":"Investigating factors associated with depression of vitiligo patients in Singapore","volume":"21","author":"Chan","year":"2011","journal-title":"J Clin Nurs"},{"key":"2023011316192313300_bjd16049-bib-0044","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jaad.2010.05.031","article-title":"Application of a two-question screening instrument to detect depressive symptoms in patients with vitiligo: a pilot study","volume":"64","author":"Yamamoto","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2340\/00015555-1520","article-title":"Quality of life and emotional state in vitiligo in an Estonian sample: Comparison with psoriasis and healthy controls","volume":"93","author":"Karelson","year":"2013","journal-title":"Acta Dermato Venereologica."},{"key":"2023011316192313300_bjd16049-bib-0046","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijn.12179","article-title":"Investigating factors associated with quality of life of vitiligo patients in Singapore","volume":"19","author":"Chan","year":"2013","journal-title":"Int J Nurs Pract"},{"key":"2023011316192313300_bjd16049-bib-0047","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jdv.12216","article-title":"Quantification and comparison of psychiatric distress in African patients with albinism and vitiligo: a 5-year prospective study","volume":"28","author":"Ajose","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023011316192313300_bjd16049-bib-0048","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/0253-7176.135385","article-title":"Psychiatric morbidity and quality of life in vitiligo patients","volume":"36","author":"Ramakrishna","year":"2014","journal-title":"Indian J Psychol Med"},{"key":"2023011316192313300_bjd16049-bib-0049","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2310\/7750.2014.14110","article-title":"The prevalence of anxiety and depression in Arab dermatology patients","volume":"19","author":"Alshahwan","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"2023011316192313300_bjd16049-bib-0050","first-page":"437","article-title":"Prevalence and frequency of depression in patients with vitiligo","volume":"4","author":"Saleki","year":"2015","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"2023011316192313300_bjd16049-bib-0051","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0972-6748.181724","article-title":"Psychiatric morbidity and quality of life in skin diseases: a comparison of alopecia areata and psoriasis","volume":"24","author":"Karia","year":"2015","journal-title":"Ind Psychiatry J"},{"key":"2023011316192313300_bjd16049-bib-0052","first-page":"70","article-title":"Psychosomatic aspects in patients with dermatologic diseases","volume":"243","author":"Tsintsadze","year":"2015","journal-title":"Georgia Medic News"},{"key":"2023011316192313300_bjd16049-bib-0053","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.det.2016.11.002","article-title":"Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients","volume":"35","author":"Elbuluk","year":"2017","journal-title":"Dermatol Clin"},{"key":"2023011316192313300_bjd16049-bib-0054","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2133.2010.09828.x","article-title":"Vitiligo linked to stigmatisation in British South Asian women: a qualitative study of the experiences of living with vitiligo","volume":"163","author":"Thompson","year":"2010","journal-title":"Br J Dermatol"},{"key":"2023011316192313300_bjd16049-bib-0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1348\/135910702169457","article-title":"Living with vitiligo: dealing with difference","volume":"7","author":"Thompson","year":"2002","journal-title":"Br J Health Psychol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16049","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.16049","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.16049","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/178\/4\/863\/47587804\/bjd0863.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/178\/4\/863\/47587804\/bjd0863.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:30:13Z","timestamp":1676367013000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/178\/4\/863\/6602463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,1]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16049","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[2018,4,1]]},"published":{"date-parts":[[2018,4,1]]}}}